trial · primary record
BI 1703880
Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 66 |
| Primary completion | 2029-01-02 |
| Primary endpoint | Occurrence of dose limiting toxicities (DLTs) during the maximum tolerated dose (MTD) evaluation period |
| Registry ID | NCT05471856 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:04.577Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05471856
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.